With the latest well-tolerated pangenotypic direct acting antivirals (DAAs) (sofosbuvir/velpatasvir or glecaprevir/pibrentasvir) [2, 3], treatment duration decreased to 812 weeks, treatment success increased to 95100% and genotyping became dispensable [4]
Martinek J, Hustak R, Mares J et al (2022) Endoscopic pyloromyotomy for the treatment of severe and refractory gastroparesis: a pilot, randomised, sham-controlled trial
Supplementary Table 2 (download XLSX Metabolomics and lipidomics
Store in a cool, dark, and dry place, preferably in the refrigerator, and keep it away from sunlight to maintain quality and integrity.
Besides, it was found that semaglutide could regulate food preference, as well as reduce food intake and weight without reducing energy consumption (170)